|
1. Stella A, Lastella P, Loconte DC, Bukvic N, Varvara D, Patruno M, et al. Accurate Classification of NF1 Gene Variants in 84 Italian Patients with Neurofibromatosis Type 1. Genes 2018; 9(4): 216. 2. Longo JF, Weber SM, Turner-Ivey BP, Carroll SL. Recent Advances in the Diagnosis and Pathogenesis of Neurofibromatosis Type 1 (NF1)-associated Peripheral Nervous System Neoplasms. Adv Anat Pathol 2018; 25(5): 353-68. 3. Lv M, Zhao W, Yan L, Chen L, Cui K, Gao J, et al. Screening for mutation site on the type I neurofibromatosis gene in a family. Childs Nerv Syst 2012; 28(5): 721-7. 4. Bora Carman K, Yakut A, Anlar B, Ayter S. Case Report: Spinal neurofibromatosis associated with classical neurofibromatosis type 1: genetic characterisation of an atypical case. BMJ Case Rep 2013; bcr2012008468. 5. Malbari F, Spira M, B Knight P, Zhu C, Roth M, Gill J, et al. Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis: Impact of Family History. J Pediatr Hematol Oncol 2018; 40(6): e359-e363. 6. Messiaen LM, Callens T, Mortier G, Beysen D, Vandenbroucke I, Van Roy N, et al. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 2000; 15(6): 541-55. 7. Zapata Laguado MI, Lizarazo Hurtado DV, Bonilla Gomez CE. Neurofibromatosis Type 1 - Association with Breast Cancer, Basal Cell Carcinoma of the Skin, and Low-Grade Peripheral Nerve Sheath Sarcoma: Case Report and Literature Review. Case Rep Oncol 2019; 12(1): 228–34. 8. Johannessen CM, Reczek EE, James MF, Brems H, Legius E, Cichowski K. The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc Natl Acad Sci 2005; 102(24): 8573-8 . 9. Zhang J, Tong H, Fu Xa, Fu X, Zhang Y, Liu J, et al. Molecular characterization of NF1 and neurofibromatosis type 1 genotype-phenotype correlations in a Chinese population. Sci Rep 2015; 5: 11291. 10. Koczkowska M, Chen Y, Callens T, Gomes A, Sharp A, Johnson S et al. Genotype-phenotype correlation in NF1: Evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844–848. Am J Hum Genet 2018; 102(1): 69-87. 11. Ars E, Kruyer H, Morell M, Pros E, Serra E, Ravella A, et al. Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients. J Med Genet 2003; 40(6): e82. 12. Riva M, Martorana D, Uliana V, Caleffi E, Boschi E, Garavelli L, et al. Recurrent NF1 gene variants and their genotype/phenotype correlations in patients with Neurofibromatosis type I. Genes Chromosom Cancer 2022; 61(1): 10-21. 13. Xu W, Yang X, Hu X, Li S. Fifty-four novel mutations in the NF1 gene and integrated analyses of the mutations that modulate splicing. Int J Mol Med 2014; 34(1): 53-60. 14. Sabbagh A, Pasmant E, Imbard A, Luscan A, Soares M, Blanché H, et al. NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience. Hum Mutat 2013; 34(11): 1510-8. 15. Napolitano F, Dell’Aquila M, Terracciano C, Franzese G, Gentile M, Piluso G, et al. Genotype-Phenotype Correlations in Neurofibromatosis Type 1: Identification of Novel and Recurrent NF1 Gene Variants and Correlations with Neurocognitive Phenotype. Genes 2022; 13: 1130. 16. Foji S, Dorgaleleh S, Oladnabi M, Jouybari L, NF1. Mutations Analysis Using Whole Exome Sequencing Technique in 11 Unrelated Iranian Families with Neurofibromatosis Type 1. Int J Pediatr 2020; 8(5): 11311-319. 17. Britney N. Wilson, BA, MS, Ann M. John, MD, Marc Zachary Handler, et al. Neurofibromatosis Type 1: New Developments in Genetics and Treatment. J Am Acad Dermatol 2020; 48(6): 1667-76. 18. Valero MC, Martín Y, Hernández-Imaz E, Hernández AM, Meleán G, Valero AM, et al. A highly sensitive genetic protocol to detect NF1 mutations. J Mol Diagn 2011; 13(2): 113-22.
|
.png)
.png){kind=logo}
